Cervical dysplasia, also known as cervical intraepithelial neoplasia (CIN), is a premalignant transformation, which is characterized by abnormal growth of cells over the surface of the cervix. This condition is curable and is not considered as cancer and ranges from mild to severe forms depending upon the concentration of abnormal cell formation. However, sometimes this disease may not require intervention and can eliminate on its own due to strong immune response, and if left untreated it may also lead to cervical cancer. Chronic form of cervical dysplasia is mainly caused due to infection of the cervix with sexually transmitted human papilloma viruses, especially through its 16 and 18 types. This disease is very common among females of age between 25 to 35 years of age, but it can affect women of all age groups. Cervical dysplasia can also be caused in people having multiple sex partners, early pregnancy or early child birth, and other illnesses and is often devoid of any visible symptoms, but it can be detected via human papilloma virus DNA test. Cervical dysplasia can be treated via monotherapy or combination drugs, ablation therapy and resection (removal of the abnormal area) therapy. On the basis of the degree of the condition the cervical dysplasia market can be classified into three major segments namely, mild dysplasia (CIN1), moderate dysplasia (CIN2) and severe dysplasia to cancer (CIN3).
Major driving factors for the growth of cervical dysplasia market include, increasing occurrences of various sexually transmitted diseases (STDs), increasing smoking habits, alcohol and drug abuse, increasing usage of immunosuppressant drugs and others. The increasing prevalence of various STDs has considerably increased the chances of occurrence of several mild to severe forms of cervical dysplasia. Moreover, increasing prevalence of CIN, thus can also lead to cervical cancer, where mild and severe CIN can be treated via several therapeutic procedures, thus contributing towards the growth of this market. Increasing use of tobacco, smoking and drug abuse also increase the chances of contracting this disease, and global rise in smoking habits will also contribute towards this market’s growth. Increasing disease forms have led to growth in usage of various drugs including immunosuppressants that can rise in the risk of contracting this disease. Recent technological advancements in therapeutic procedures for treating various forms of this disease have also caused an increased demand world over, which will continue to contribute towards the growth of cervical dysplasia treatments market.
Geographically, North America dominates the cervical dysplasia market followed by Europe. Major factors responsible for the dominance of these regions over other markets were high awareness levels among people about the disease and its treatments as well as well-established healthcare infrastructure in these regions. Asia-Pacific region holds immense potential for growth as this region shown the fastest growth in the segment. Major factors responsible for this region’s fast rate of growth were increasing disease occurrences and increasing awareness about the disease and its treatments. Demand for advanced treatment options, current advancements and the ongoing clinical trials to enhance the therapeutics for the disease will also contribute towards the growth of Asia-Pacific cervical dysplasia treatments market. Some of the key players operating in the cervical dysplasia market are Advaxis, Inc., AnGes MG, Inc., Eisai, Inc., GlaxoSmithKline plc, Inovio Biomedical Corporation, and Photocure ASA.
This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include
- North America
- Asia Pacific
- Rest of the World
This report provides comprehensive analysis of
- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for upcoming years
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.
Reasons for Buying this Report
- This report provides pin-point analysis for changing competitive dynamics
- It provides a forward looking perspective on different factors driving or restraining market growth
- It provides a technological growth map over time to understand the industry growth rate
- It provides a seven-year forecast assessed on the basis of how the market is predicted to grow
- It helps in understanding the key product segments and their future
- It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
- It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
- It provides distinctive graphics and exemplified SWOT analysis of major market segments